Trials
Search / Trial NCT05638074

Does the Presence of Cervical Facet Tropism Affect the Response to Interlaminar Epidural Steroid Injections?

Launched by JANBUBI JANDAULYET · Nov 25, 2022

Trial Information

Current as of January 13, 2025

Unknown status

Keywords

Facet Tropism Cervical Disc Herniation Cervical Radicular Pain

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • aged 18-75 years, who applied to the pain medicine outpatient clinic, had axial neck and unilateral radicular extremity pain for at least 3 months, and were diagnosed with protruded disc herniation by magnetic resonance imaging were included in the study
  • Exclusion Criteria:
  • Patients with systemic inflammatory disease, bleeding diathesis,history of psychiatric illness, malignancy, contrast material or local anesthetic agent allergy, cervical spinal stenosis, history of cervical ESI, or neck surgery in the last 3 months were excluded from the study

Trial Officials

Osman Hakan Gunduz, Professor

Study Director

Marmara University

About Janbubi Jandaulyet

Janbubi Jandaulyet is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapies and treatment modalities, the organization collaborates with leading healthcare professionals and research institutions to conduct rigorous clinical trials across various therapeutic areas. Janbubi Jandaulyet prioritizes ethical standards, regulatory compliance, and patient safety, ensuring that each trial is designed to generate reliable data that can contribute to the development of effective healthcare solutions. Through its commitment to scientific excellence and collaboration, Janbubi Jandaulyet aims to make meaningful contributions to the field of medicine.

Locations

Istanbul, Pendik, Turkey

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials